Alternative Splicing Regulation: Isoform-Level Validation

A change in percent-spliced-in (PSI) for one exon is a measurement of a ratio between transcripts. It does not tell you which isoform is functional, whether the change is direct, or whether the protein output changed in the direction you claim.

Three questions need separate answers:

1. Which isoforms changed — not just the inclusion ratio of one exon.
2. What caused the change — a splicing factor, a regulatory element, or a transcription-coupled effect.
3. What the protein consequence is — because isoform ratios can shift substantially with little change in functional protein.

Most published splicing claims answer only the first, approximately.

Practical guidance: use short-read for discovery, then confirm the specific isoforms with targeted amplicons or long reads. Report junction counts alongside PSI, since PSI from low coverage is unstable.

Four designs, in ascending order of strength:

1. Correlate with a splicing factor. Perturb the candidate factor (knockdown or knockout) and measure the exon. Cheap; establishes dependence, not directness.

2. Minigene reporter. Clone the exon with flanking introns and regulatory elements, mutate candidate binding sites, and measure inclusion. Establishes that sequences within the construct are sufficient — with the caveat that minigenes remove native chromatin context and long-range elements.

3. Endogenous element mutation. Delete or mutate the predicted regulatory site in the genome and measure the endogenous exon. Stronger than a minigene, and increasingly feasible with base and prime editing.

4. Tethering. Recruit the candidate factor to a reporter or an endogenous site; if inclusion changes, sufficiency is supported. The most mechanistic of the four and the least used.

A defensible claim usually combines 1 and 3, with 2 or 4 as supporting evidence.

A shift in PSI matters only if it changes protein. Three levels of evidence:

• • Predicted consequence: in-frame versus frameshift, domain inclusion or loss, nonsense-mediated decay susceptibility. Report it, but do not present it as a result.
• • Isoform-resolved protein detection: isoform-specific antibodies where available, or targeted proteomics with isoform-distinguishing peptides.
• • Functional assay: an assay that depends on the domain affected by the splice change.

A common weakness: reporting a 30% PSI shift of an exon whose inclusion changes no annotated domain, with no protein data. That is a splicing observation, not a functional claim.

The third row is routinely omitted and is the fastest way to show the assay works.

Splicing changes can arise without any splicing-factor effect: altered transcription rate, Pol II elongation, or chromatin state can change exon inclusion co-transcriptionally.

Signals that the effect is transcriptional: the whole gene's expression changes alongside the ratio, the effect disappears when transcription is controlled for, or nascent RNA shows the change before mature RNA.

Interpretation matters here: a splicing-factor knockdown that also reduces transcription of the target gene has not demonstrated a splicing mechanism.

EDITGENE builds splicing models: endogenous regulatory-site mutations by base or prime editing, minigene-validated elements, splicing-factor knockout lines, and isoform-resolved readouts including targeted long-read sequencing.

Tell us the exon and the factor. Contact EDITGENE to request a project consultation or quote.

Isoform quantification depends on annotation, coverage, and junction read support; PSI values from low-coverage data are unreliable and should be reported with counts.

PSI changes are not automatically functional. Protein-level or domain-specific evidence is required before a splicing change is described as a mechanism.

• • Wang ET, et al. Alternative isoform regulation in human tissue transcriptomes. Nature. 2008;456:470–476.
• • Ule J, Blencowe BJ. Alternative splicing regulatory networks: functions, mechanisms, and evolution. Molecular Cell. 2019;76:329–345.
• • Trapnell C, et al. Transcript assembly and quantification by RNA-seq reveals unannotated transcripts and isoform switching during cell differentiation. Nature Biotechnology. 2010;28:511–515.
• • Rogalska ME, et al. Regulation of pre-mRNA splicing: roles in physiology and disease, and therapeutic prospects. Nature Reviews Genetics. 2023;24:251–269.